NU-MED Centrum Diagnostyki i Terapii Onkologicznej
Tomaszow Mazowiecki, Poland
Hospital in Tomaszów Mazowiecki
Jana Pawła II 35, 97-200 Tomaszów Mazowiecki
About NU-MED Centrum Diagnostyki i Terapii Onkologicznej
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
1
Polish Lymphoma Research Group
1
Clinical Trials at NU-MED Centrum Diagnostyki i Terapii Onkologicznej
During the past decade, NU-MED Centrum Diagnostyki i Terapii Onkologicznej conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study of Atezolizumab as Monotherapy and in Combination With Platinum-Based Chemotherapy in Participants With Untreated Locally Advanced or Metastatic Urothelial Carcinoma
2016-06-30
2023-06-30
Active, not recruiting
1,214
The Efficacy of Bendamustine, Gemcytabine, Dexamethasone Salvage Chemotherapy With Autologous Stem Cell Transplantation (BURGUND) Consolidation in Advanced Classical Hodgkin Lymphoma Patients Not Responding to ABVD Therapy
2017-11-06
2023-09-30
Active, not recruiting
115
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at NU-MED Centrum Diagnostyki i Terapii Onkologicznej
According to Clinical.Site data, the most researched conditions in "NU-MED Centrum Diagnostyki i Terapii Onkologicznej" are
"Hodgkin's Lymphoma" (1 trials) and "Urothelial Carcinoma" (1 trials). Many other conditions were trialed in "NU-MED Centrum Diagnostyki i Terapii Onkologicznej" in a lesser frequency.
Clinical Trials Intervention Types at NU-MED Centrum Diagnostyki i Terapii Onkologicznej
Most popular intervention types in "NU-MED Centrum Diagnostyki i Terapii Onkologicznej" are "Drug" (2 trials), "Diagnostic Test" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Gemcitabine" (2 trials), "Atezolizumab" (1 trials), "Autologous Stem Cell Transplant" (1 trials), "Bendamustine" (1 trials) and "Carboplatin" (1 trials). Other intervention names were less common.
Clinical Trials Genders at NU-MED Centrum Diagnostyki i Terapii Onkologicznej
The vast majority of trials in "NU-MED Centrum Diagnostyki i Terapii Onkologicznej" are
2 trials for "All" genders.
Clinical Trials Status at NU-MED Centrum Diagnostyki i Terapii Onkologicznej
Currently, there are NaN active trials in "NU-MED Centrum Diagnostyki i Terapii Onkologicznej".
undefined are not yet recruiting,
undefined are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in NU-MED Centrum Diagnostyki i Terapii Onkologicznej,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in NU-MED Centrum Diagnostyki i Terapii Onkologicznej, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".